105 related articles for article (PubMed ID: 20974225)
21. Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor.
Kimura R; MacTavish D; Yang J; Westaway D; Jhamandas JH
J Neurosci; 2012 Nov; 32(48):17401-6. PubMed ID: 23197731
[TBL] [Abstract][Full Text] [Related]
22. Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor.
Dinklo T; Shaban H; Thuring JW; Lavreysen H; Stevens KE; Zheng L; Mackie C; Grantham C; Vandenberk I; Meulders G; Peeters L; Verachtert H; De Prins E; Lesage AS
J Pharmacol Exp Ther; 2011 Feb; 336(2):560-74. PubMed ID: 21084390
[TBL] [Abstract][Full Text] [Related]
23. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.
Moriguchi S; Shioda N; Han F; Yeh JZ; Narahashi T; Fukunaga K
Hippocampus; 2009 Sep; 19(9):844-54. PubMed ID: 19253410
[TBL] [Abstract][Full Text] [Related]
24. Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP.
Welsby PJ; Rowan MJ; Anwyl R
Neuropharmacology; 2007 Jul; 53(1):188-95. PubMed ID: 17610911
[TBL] [Abstract][Full Text] [Related]
25. [Neuroprotective effects of alpha7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer's disease].
Qi XL; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):51-5. PubMed ID: 18509986
[TBL] [Abstract][Full Text] [Related]
26. Alpha-7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: an effect similar to antipsychotics.
Hansen HH; Timmermann DB; Peters D; Walters C; Damaj MI; Mikkelsen JD
J Neurosci Res; 2007 Jun; 85(8):1810-8. PubMed ID: 17455307
[TBL] [Abstract][Full Text] [Related]
27. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
[TBL] [Abstract][Full Text] [Related]
28. Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation.
Kimura R; MacTavish D; Yang J; Westaway D; Jhamandas JH
Mol Neurobiol; 2017 Jan; 54(1):748-754. PubMed ID: 26768593
[TBL] [Abstract][Full Text] [Related]
29. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
Qi XL; Nordberg A; Xiu J; Guan ZZ
Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
[TBL] [Abstract][Full Text] [Related]
30. Activation of α7 nicotinic receptor affects APP processing by regulating secretase activity in SH-EP1-α7 nAChR-hAPP695 cells.
Nie HZ; Shi S; Lukas RJ; Zhao WJ; Sun YN; Yin M
Brain Res; 2010 Oct; 1356():112-20. PubMed ID: 20708605
[TBL] [Abstract][Full Text] [Related]
31. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
32. The partial alpha7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus.
Lagostena L; Trocme-Thibierge C; Morain P; Cherubini E
Neuropharmacology; 2008 Mar; 54(4):676-85. PubMed ID: 18187166
[TBL] [Abstract][Full Text] [Related]
33. Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release.
Bortz DM; Mikkelsen JD; Bruno JP
Neuroscience; 2013; 255():55-67. PubMed ID: 24095692
[TBL] [Abstract][Full Text] [Related]
34. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
35. Mossy fiber long-term potentiation deficits in BACE1 knock-outs can be rescued by activation of alpha7 nicotinic acetylcholine receptors.
Wang H; Song L; Lee A; Laird F; Wong PC; Lee HK
J Neurosci; 2010 Oct; 30(41):13808-13. PubMed ID: 20943921
[TBL] [Abstract][Full Text] [Related]
36. Nicotine reverses consolidated long-term potentiation in the hippocampal CA1 region.
Guan X; Nakauchi S; Sumikawa K
Brain Res; 2006 Mar; 1078(1):80-91. PubMed ID: 16564510
[TBL] [Abstract][Full Text] [Related]
37. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF
Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877
[TBL] [Abstract][Full Text] [Related]
38. Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction.
Yamazaki Y; Jia Y; Hamaue N; Sumikawa K
Eur J Neurosci; 2005 Aug; 22(4):845-60. PubMed ID: 16115208
[TBL] [Abstract][Full Text] [Related]
39. Nicotine accelerates reversal of long-term potentiation and enhances long-term depression in the rat hippocampal CA1 region.
Fujii S; Sumikawa K
Brain Res; 2001 Mar; 894(2):340-6. PubMed ID: 11251213
[TBL] [Abstract][Full Text] [Related]
40. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
